Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Peifeng Lin
affiliation not provided to SSRN
Contact
affiliation not provided to SSRN
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
66
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Psoralidin enhances the sensitivity of breast cancer to cisplatin by targeting Nr1i2
Number of pages: 42
Posted: 23 Oct 2025
Meigong Zhong
,
Meimei Wu
,
Ruizhen Chen
,
Jiadi He
,
Yulan Qiu
,
Jing Huang
,
Yanyang Mai
,
Wenjie Lu
,
Wanting Wu
,
Mingzhu Zheng
,
Xiaoxue Huang
,
Jie Ling
,
Liangliang Ren
,
Minxian Li
, Peifeng Lin,
Minli Chen
,
Qin Zhang
,
KwanNin To
,
Yu Wang
,
Dong Ren
,
Lili Wang
,
Zhonglin Xue
and
Xin Zhang
affiliation not provided to SSRN
, Jiangmen Central Hospital,
affiliation not provided to SSRN
, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital, Jiangmen Central Hospital,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Jinan University, Jinan University,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Jiangmen Central Hospital and Jiangmen Central Hospital
Downloads
66
(907,769)
View PDF
Download
Abstract:
Breast cancer, Psoralidin, Cisplatin, Nr1i2, combination treatment
Feedback